By Susan Kelly (Reuters) - Express Scripts, the largest U.S. pharmacy benefit manager, on Tuesday said cost savings on expensive cancer treatments could be achieved if the company were involved earlier in the decision-making process. Express Scripts, which has become more aggressive in negotiating discounts on drugs for insurance plans and employers, in December stopped covering Gilead Sciences Inc's hepatitis C treatment after lining up a cheaper price for AbbVie Inc's newly-approved alternative. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment